SW

Simon Edward Ward

GL Glaxo Group Limited: 11 patents #73 of 1,368Top 6%
CL Convergence Pharmaceuticals Limited: 4 patents #9 of 38Top 25%
Johnson & Johnson: 4 patents #2,223 of 7,810Top 30%
UL University College Cardiff Consultants Limited: 3 patents #16 of 276Top 6%
VL Vernalis Research Limited: 3 patents #23 of 57Top 45%
📍 Cardiff, GB: #3 of 510 inventorsTop 1%
Overall (All Time): #159,644 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Showing 1–25 of 25 patents

Patent #TitleCo-InventorsDate
12383540 Compounds that modulates AMPA receptor function Paul John Beswick, Lewis Pennicott, Tristan REUILLON, Irina Chuckowree, Carolina Villalonga-Barber +1 more 2025-08-12
RE49517 Pyrazoles Rudolf Schindler, Hans-Joachim Lankau, Norbert Höfgen, Christian Grunwald, Ute Egerland +3 more 2023-05-02
11298345 Compounds that modulates AMPA receptor function Paul John Beswick, Lewis Pennicott, Tristan REUILLON, Irina Chuckowree, Carolina Villalonga-Barber +1 more 2022-04-12
11186567 AMPA receptor potentiators Paul John Beswick, Lewis Pennicott, Tristan REUILLON 2021-11-30
10323021 Triazoles as NR2B receptor inhibitors Rudolf Schindler, Hans-Joachim Lankau, Norbert Höfgen, Ute Egerland, Barbara Langen +1 more 2019-06-18
10155727 Pyrazoles Rudolf Schindler, Hans-Joachim Lankau, Norbert Höfgen, Christian Grunwald, Ute Egerland +3 more 2018-12-18
9981950 Triazoles as NR2B receptor inhibitors Rudolf Schindler, Hans-Joachim Lankau, Norbert Höfgen, Ute Egerland, Barbara Langen +1 more 2018-05-29
9750719 Tetrazole compounds as calcium channel blockers Paul John Beswick, Robert James Gleave, Shuji Hachisu, Sadie Vile, Nicolas Bertheleme 2017-09-05
9115132 Tetrazole compounds as calcium channel blockers Paul John Beswick, Robert James Gleave, Shuji Hachisu, Sadie Vile, Nicholas Bertheleme 2015-08-25
8933132 Tricyclic substituted benzenesulfonamide piperazine derivatives as CAV2.2 calcium channel blockers David Norton, Daniele Andreotti, Roberto Profeta, Simone Spada, Helen Susanne Price 2015-01-13
8173820 Compounds which potentiate the AMPA receptor and uses thereof in medicine Nicolas Bertheleme, Wai Ngor Chan, Jaqueline Sandra Scott 2012-05-08
8093249 Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives Jag Paul Heer, David Norton 2012-01-10
7790758 Compounds which potentiate glutamate receptor and uses thereof in medicine Daniele Andreotti, Luca Arista, Francesca Cardullo, Simone Spada, Kevin Thewlis 2010-09-07
7741351 Compounds which potentiate glutamate receptor and uses thereof in medicine Kevin Thewlis 2010-06-22
7732600 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi +7 more 2010-06-08
7642256 Compounds which potentiate AMPA receptor and uses thereof in medicine Stephen Harrison, Kevin Thewlis 2010-01-05
7618969 Compounds which potentiate glutamate receptor and uses thereof in medicine Daniel Marcus Bradley, Kevin Thewlis 2009-11-17
7592346 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi +7 more 2009-09-22
7572819 Compounds which potentiate glutamate receptor and uses thereof in medicine Daniel Marcus Bradley, Kevin Thewlis 2009-08-11
7566735 Compounds which potentiate AMPA receptor and uses thereof in medicine Stephen Harrison, Kevin Thewlis 2009-07-28
7244726 Heterocyclic compounds possessing affinity at 5HT1 -type receptors and use thereof in therapy Frank Peter Harrington, Paul William Smith 2007-07-17
7214674 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors 2007-05-08
6583156 4-Quinolinemethanol derivatives as purine receptor antagonists (1) Roger John Gillespie, Joanne Lerpiniere, Suneel Gaur, David Reginald Adoms, Lars Jacob Stray Knutsen 2003-06-24
6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission Roger John Gillespie, Nathaniel Julius Thomas Monck, Andrew James Bird 2003-03-11
6500866 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission Roger John Gillespie, Michael Fredrick Snape 2002-12-31